… Giovanni Ciancio … Trotta F, Dovigo L, Scapoli G, Cavazzini L, Castoldi G (1993)
Immunoblastic malignant lymphoma in adult onset Still’s disease. J Rheumatol 20:1788–1792 …

… FSGS recurrence was defined as a spot urine protein/creatinine ratio of >3.5 g/g during the
first 30 days after transplantation in any morning collection. The need for plasmapheresis, as …

… In 2000 Ciancio et al described the piggyback technique as well as the conventional
technique of liver mobilization through a modified cruciate incision and the Rochard retractor as a …

Renal cell carcinoma (RCC) extension into the renal vein or the inferior vena cava occurs in
4 %–10 % of all kidney cancer cases. This entity shows a wide range of different clinical and …

Reported are the reduction of anti-HLA antibody levels and improvement of transplant rates
by intravenous immunoglobulin (IVIG) in a randomized, double-blind, placebo-controlled …

<p id="p001">Abatacept (cytotoxic T-lymphocyte–associated antigen 4–immunoglobulin
fusion protein [CTLA-4–Ig]) is a costimulatory inhibitor that targets B7-1 (CD80). The present …

OBJECTIVE To investigate if recurrent autoimmunity explained hyperglycemia and C-peptide
loss in three immunosuppressed simultaneous pancreas-kidney (SPK) transplant …

Background. New trends in immunosuppression in clinical transplantation include the use
of antibody induction agents in protocols that emphasize reduction or avoidance of steroids …

BACKGROUND: The prognostic significance of venous involvement and tumour thrombus
level in renal cell carcinoma (RCC) remains highly controversial. In 2010, the American Joint …

Altered degradation of extracellular matrix has been implicated in the pathogenesis of
hepatic fibrosis. We investigated levels and cellular sites of gene expression of two major …